Sept4, a component of presynaptic scaffold and Lewy bodies, is required for the suppression of alpha-synuclein neurotoxicity - PubMed (original) (raw)

. 2007 Feb 15;53(4):519-33.

doi: 10.1016/j.neuron.2007.01.019.

Nobuyuki Yamasaki, Akari Hagiwara, Ai Tanigaki, Ayumi Kitano, Rie Hikawa, Hidekazu Tomimoto, Makoto Noda, Masashi Takanashi, Hideo Mori, Nobutaka Hattori, Tsuyoshi Miyakawa, Makoto Kinoshita

Affiliations

• PMID: 17296554
• DOI: 10.1016/j.neuron.2007.01.019

Free article

Sept4, a component of presynaptic scaffold and Lewy bodies, is required for the suppression of alpha-synuclein neurotoxicity

Masafumi Ihara et al. Neuron. 2007.

Free article

Abstract

In Parkinson disease (PD), alpha-synuclein aggregates called Lewy bodies often involve and sequester Septin4 (Sept4), a polymerizing scaffold protein. However, the pathophysiological significance of this phenomenon is unclear. Here, we show the physiological association of Sept4 with alpha-synuclein, the dopamine transporter, and other presynaptic proteins in dopaminergic neurons; mice lacking Sept4 exhibit diminished dopaminergic neurotransmission due to scarcity of these presynaptic proteins. These data demonstrate an important role for septin scaffolds in the brain. In transgenic mice that express human alpha-synuclein(A53T) (a mutant protein responsible for familial PD), loss of Sept4 significantly enhances neuropathology and locomotor deterioration. In this PD model, insoluble deposits of Ser129-phosphorylated alpha-synuclein(A53T) are negatively correlated with the dosage of Sept4. In vitro, direct association with Sept4 protects alpha-synuclein against self-aggregation and Ser129 phosphorylation. Taken together, these data show that Sept4 may be involved in PD as a dual susceptibility factor, as its insufficiency can diminish dopaminergic neurotransmission and enhance alpha-synuclein neurotoxicity.

PubMed Disclaimer

Comment in

• Climbing the scaffolds of Parkinson's disease pathogenesis.
  Spencer B, Crews L, Masliah E. Spencer B, et al. Neuron. 2007 Feb 15;53(4):469-70. doi: 10.1016/j.neuron.2007.02.002. Neuron. 2007. PMID: 17296545

Similar articles

• Expression of Lewy body protein septin 4 in postmortem brain of Parkinson's disease and control subjects.
  Shehadeh L, Mitsi G, Adi N, Bishopric N, Papapetropoulos S. Shehadeh L, et al. Mov Disord. 2009 Jan 30;24(2):204-10. doi: 10.1002/mds.22306. Mov Disord. 2009. PMID: 18951507
• Chronic overload of SEPT4, a parkin substrate that aggregates in Parkinson's disease, causes behavioral alterations but not neurodegeneration in mice.
  Ageta-Ishihara N, Yamakado H, Morita T, Hattori S, Takao K, Miyakawa T, Takahashi R, Kinoshita M. Ageta-Ishihara N, et al. Mol Brain. 2013 Aug 11;6:35. doi: 10.1186/1756-6606-6-35. Mol Brain. 2013. PMID: 23938054 Free PMC article.
• Association of the cytoskeletal GTP-binding protein Sept4/H5 with cytoplasmic inclusions found in Parkinson's disease and other synucleinopathies.
  Ihara M, Tomimoto H, Kitayama H, Morioka Y, Akiguchi I, Shibasaki H, Noda M, Kinoshita M. Ihara M, et al. J Biol Chem. 2003 Jun 27;278(26):24095-102. doi: 10.1074/jbc.M301352200. Epub 2003 Apr 14. J Biol Chem. 2003. PMID: 12695511
• The role of Ser129 phosphorylation of α-synuclein in neurodegeneration of Parkinson's disease: a review of in vivo models.
  Sato H, Kato T, Arawaka S. Sato H, et al. Rev Neurosci. 2013;24(2):115-23. doi: 10.1515/revneuro-2012-0071. Rev Neurosci. 2013. PMID: 23314528 Review.
• Alpha-synuclein and presynaptic function: implications for Parkinson's disease.
  Lykkebo S, Jensen PH. Lykkebo S, et al. Neuromolecular Med. 2002;2(2):115-29. doi: 10.1385/NMM:2:2:115. Neuromolecular Med. 2002. PMID: 12428807 Review.

Cited by

• Examining the Toxicity of α-Synuclein in Neurodegenerative Disorders.
  Shan FY, Fung KM, Zieneldien T, Kim J, Cao C, Huang JH. Shan FY, et al. Life (Basel). 2021 Oct 22;11(11):1126. doi: 10.3390/life11111126. Life (Basel). 2021. PMID: 34833002 Free PMC article. Review.
• Septin 11 is present in GABAergic synapses and plays a functional role in the cytoarchitecture of neurons and GABAergic synaptic connectivity.
  Li X, Serwanski DR, Miralles CP, Nagata KI, De Blas AL. Li X, et al. J Biol Chem. 2009 Jun 19;284(25):17253-17265. doi: 10.1074/jbc.M109.008870. Epub 2009 Apr 20. J Biol Chem. 2009. PMID: 19380581 Free PMC article.
• The evolution, complex structures and function of septin proteins.
  Cao L, Yu W, Wu Y, Yu L. Cao L, et al. Cell Mol Life Sci. 2009 Oct;66(20):3309-23. doi: 10.1007/s00018-009-0087-2. Epub 2009 Jul 14. Cell Mol Life Sci. 2009. PMID: 19597764 Free PMC article. Review.
• Septins promote dendrite and axon development by negatively regulating microtubule stability via HDAC6-mediated deacetylation.
  Ageta-Ishihara N, Miyata T, Ohshima C, Watanabe M, Sato Y, Hamamura Y, Higashiyama T, Mazitschek R, Bito H, Kinoshita M. Ageta-Ishihara N, et al. Nat Commun. 2013;4:2532. doi: 10.1038/ncomms3532. Nat Commun. 2013. PMID: 24113571 Free PMC article.
• IL1RAPL1 knockout mice show spine density decrease, learning deficiency, hyperactivity and reduced anxiety-like behaviours.
  Yasumura M, Yoshida T, Yamazaki M, Abe M, Natsume R, Kanno K, Uemura T, Takao K, Sakimura K, Kikusui T, Miyakawa T, Mishina M. Yasumura M, et al. Sci Rep. 2014 Oct 14;4:6613. doi: 10.1038/srep06613. Sci Rep. 2014. PMID: 25312502 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Molecular Biology Databases

  • BioCyc
  • GlyGen glycoinformatics resource
  • Mouse Genome Informatics (MGI)
  • PhosphoSitePlus